Clinical trials
Phase 2 trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,312 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 7 |
| 2002 | 10 |
| 2003 | 11 |
| 2004 | 33 |
| 2005 | 36 |
| 2006 | 45 |
| 2007 | 41 |
| 2008 | 57 |
| 2009 | 54 |
| 2010 | 60 |
| 2011 | 62 |
| 2012 | 44 |
| 2013 | 49 |
| 2014 | 45 |
| 2015 | 62 |
| 2016 | 47 |
| 2017 | 89 |
| 2018 | 64 |
| 2019 | 69 |
| 2020 | 65 |
| 2021 | 83 |
| 2022 | 61 |
| 2023 | 56 |
| 2024 | 69 |
| 2025 | 44 |
| 2026 | 28 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 835 |
| Terminated | 141 |
| Recruiting | 106 |
| Active, not recruiting | 99 |
| Unknown status | 88 |
| Withdrawn | 23 |
| Not yet recruiting | 18 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rigshospitalet, Denmark | 65 |
| AstraZeneca | 61 |
| Novartis Pharmaceuticals | 54 |
| University of Aarhus | 45 |
| GlaxoSmithKline | 34 |
| Boehringer Ingelheim | 31 |
| Novo Nordisk A/S | 30 |
| Bayer | 29 |
| Hoffmann-La Roche | 28 |
| Bristol-Myers Squibb | 24 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 42 |
| Breast Neoplasms | 36 |
| Neoplasms | 35 |
| Colorectal Neoplasms | 28 |
| Multiple Myeloma | 28 |
| Heart Failure | 25 |
| Pulmonary Disease, Chronic Obstructive | 25 |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Diabetes Mellitus | 24 |
| Renal Insufficiency, Chronic | 22 |
Trials
Showing 1 to 25 of 1,312. Each trial links to its page on Pharma Observatory.
1,212 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.